Deciphera Pharmaceuticals, Inc. Annual Operating Income (Loss) in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Deciphera Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2015 to 2023.
  • Deciphera Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$48.8M, a 8.28% increase year-over-year.
  • Deciphera Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$207M, a 9.23% decline year-over-year.
  • Deciphera Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$211M, a 15.5% decline from 2022.
  • Deciphera Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$183M, a 39.1% increase from 2021.
  • Deciphera Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$300M, a 10.7% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$211M -$28.2M -15.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-07
2022 -$183M +$117M +39.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-07
2021 -$300M -$28.9M -10.7% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-07
2020 -$271M -$70.5M -35.1% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-07
2019 -$201M -$96.6M -92.8% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-08
2018 -$104M -$53.2M -104% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-09
2017 -$50.9M -$25.1M -97.1% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-09
2016 -$25.8M -$8.23M -46.7% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-14
2015 -$17.6M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.